Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

AstraZeneca grants $2.5 million to 14 U.S.-based organizations to improve cardiovascular health

The AstraZeneca HealthCare Foundation today announced grants totaling more than $2.5 million to 14 U.S.-based nonprofit organizations from Maine to California dedicated to improving cardiovascular health in local communities.

8 Mar 2011

Scientists discover SNPs linked with high risk of sick sinus syndrome

Scientists at deCODE genetics and academic colleagues from Iceland, The Netherlands, Denmark, USA and Illumina, Inc., today report the discovery of single-letter variants in the sequence of the human genome associated with high risk of sick sinus syndrome.

6 Mar 2011

Scientists identify regulatory T cells responsible for limiting immune response

Scientists from the Walter and Eliza Hall Institute have identified the key immune cell population responsible for regulating the body's immune response.

6 Mar 2011

DIR's 'Carnival for a Cure' program to discuss about life with diabetes

Hundreds of families have come to expect a whirlwind of surprises at the always-entertaining Carnival for a Cure, benefiting the Diabetes Research Institute. At this year's 6th annual affair, to be held on Sunday, March 13, 2011 from 1 p.m. to 4 p.m. at the Metropolitan Pavilion located at 125 W. 18th St., guests will enjoy a special appearance by Nick Jonas, who will talk about life with diabetes during the program.

5 Mar 2011

Combination therapy may reduce albuminuria in patients with type 2 diabetes: Study

Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. The published study results suggest that atrasentan, used in conjunction with renin-angiotensin system inhibitors, may reduce albuminuria (presence of protein in urine) for patients with type 2 diabetes.

5 Mar 2011

European Commission approves BMY's ONGLYZA to treat type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.

4 Mar 2011

Researchers demonstrate potential neurochemical mechanism of weight loss

An interdisciplinary group of researchers at the University of Pennsylvania has, for the first time, identified the neurological and cellular signaling mechanisms that contribute to satiety - the sensation of feeling full - and the subsequent body-weight loss produced by drugs used to treat type 2 diabetes. More comprehensive knowledge of these mechanisms could form the basis for anti-obesity medications.

4 Mar 2011

BMC partners with YMCA of Greater Boston to form END Diabetes Program

In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes Program.

3 Mar 2011

New study provides fascinating insight into genetic basis of bipolar disorder

A new study provides fascinating insight into the genetic basis of bipolar disorder, a highly heritable mood disorder characterized by recurrent episodes of mania and depression.

3 Mar 2011

Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

Depomed, Inc. announced today that it has completed enrollment of Breeze 3, the company's pivotal Phase 3 clinical trial evaluating Serada for the non-hormonal treatment of menopausal hot flashes.

3 Mar 2011

New study: Lower potassium levels may help explain racial disparity in type 2 diabetes

Lower potassium levels in the blood may help explain why African-Americans are twice as likely to be diagnosed with type 2 diabetes as whites, according to a new study by Johns Hopkins researchers.

3 Mar 2011

Study identifies key gene mutation responsible for type 2 diabetes in nearly 10% of patients

A multinational study has identified a key gene mutation responsible for type 2 diabetes in nearly 10 percent of patients of white European ancestry.

2 Mar 2011

Researchers find mineral deficiency increases type 2 diabetes risk in African-Americans

Lower potassium levels in the blood may help explain why African-Americans are twice as likely to be diagnosed with type 2 diabetes as whites, according to a new study by Johns Hopkins researchers.

2 Mar 2011

CDA launches new awareness campaign about risk of developing type 2 diabetes

Today, the Canadian Diabetes Association launched "Get Checked Now" - a national public awareness campaign aimed at Canadians 40 and older alerting them to the consequences of being passive about their potential risk for developing type 2 diabetes and leading them to take action against the disease by getting checked now.

2 Mar 2011

March designated as Nutrition Month

The OPDQ is pleased that March has once again been designated as Nutrition Month. Across Quebec and the rest of Canada, dieticians/nutritionists will be holding events and activities aimed at raising public awareness about the importance of a healthful diet and teaching people how to maintain or improve their health by eating right.

2 Mar 2011

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S. Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for use with Novo Nordisk's NovoLog for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients requiring insulin.

1 Mar 2011

Omni Bio to expand Type 1 diabetes Phase I/II trial from 15 to 50 patients

Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.

28 Feb 2011

Cryo-Cell fiscal 2010 net income increases to $3.4 million

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks and an industry leader of innovative stem cell solutions, today announced results for its fiscal year 2010.

28 Feb 2011

Researchers discover new mechanism of beta cell destruction not previously known

The death of insulin-producing beta cells in the pancreas is a core defect in diabetes. Scientists in Italy and Texas now have discovered a new way that these cells die - by toxic imbalance of a molecule secreted by other pancreatic cells.

28 Feb 2011

Takeda receives Japanese approval for additional indications for NESINA

Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited's applications for two additional indications for "NESINA®" (alogliptin), combination therapy with sulfonylurea and combination therapy with biguanide for type 2 diabetes, were approved by the Japanese Ministry of Health, Labour and Welfare.

25 Feb 2011

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

AstraZeneca grants $2.5 million to 14 U.S.-based organizations to improve cardiovascular health

Scientists discover SNPs linked with high risk of sick sinus syndrome

Scientists identify regulatory T cells responsible for limiting immune response

DIR's 'Carnival for a Cure' program to discuss about life with diabetes

Combination therapy may reduce albuminuria in patients with type 2 diabetes: Study

European Commission approves BMY's ONGLYZA to treat type 2 diabetes

Researchers demonstrate potential neurochemical mechanism of weight loss

BMC partners with YMCA of Greater Boston to form END Diabetes Program

New study provides fascinating insight into genetic basis of bipolar disorder

Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

New study: Lower potassium levels may help explain racial disparity in type 2 diabetes

Study identifies key gene mutation responsible for type 2 diabetes in nearly 10% of patients

Researchers find mineral deficiency increases type 2 diabetes risk in African-Americans

CDA launches new awareness campaign about risk of developing type 2 diabetes

March designated as Nutrition Month

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

Omni Bio to expand Type 1 diabetes Phase I/II trial from 15 to 50 patients

Cryo-Cell fiscal 2010 net income increases to $3.4 million

Researchers discover new mechanism of beta cell destruction not previously known

Takeda receives Japanese approval for additional indications for NESINA

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in